In late 2020, the US Food and Drug Administration (FDA) approved a lipid-based mRNA
vaccine for the prevention of COVID-19, which has pushed this field to be more closely …

Owing to the unique DNA damaging cytotoxicity, platinum (Pt)-based chemotherapy has
long been the first-line choice for clinical oncology. Unfortunately, Pt drugs are restricted by …

Abstract Near‐infrared (NIR) laser‐induced photoimmunotherapy has aroused great interest
due to its intrinsic noninvasiveness and spatiotemporal precision, while immune evasion …

Tapping into the innate immune system's power, nanovaccines can induce tumor-specific
immune responses, which is a promising strategy in cancer immunotherapy. However …

Breast cancer is the most commonly diagnosed cancer, and surgical resection is the first
choice for its treatment. With the development of operation techniques, surgical treatment for …

The messenger RNA (mRNA) vaccines hold great significance in contagion prevention and
cancer immunotherapy. However, safely and effectively harnessing innate immunity to …

The use of cancer vaccines is considered a promising therapeutic strategy in clinical
oncology, which is achieved by stimulating antitumor immunity with tumor antigens delivered …

Cancer nanovaccines represent a promising frontier in cancer immunotherapy, utilizing
nanotechnology to augment traditional vaccine efficacy. This review comprehensively …

Dendritic cell vaccine (DCV) holds great potential in tumor immunotherapy owing to its
potent ability in eliciting tumor‐specific immune responses. Aiming at engineering enhanced …

Cancer nanovaccines have attracted widespread attention by inducing potent cytotoxic T
cell responses to improve immune checkpoint blockade (ICB) therapy, while the lack of co …